Resources | NITAG RESOURCE CENTER

2024 ∙ NACI

Guidance on an additional dose of COVID-19 vaccines in the spring for individuals at high risk of severe illness due to COVID-19

2023 ∙ CAVEI

CAVEI recommendation on updating the vaccination strategy against COVID-19 by 2024

2023 ∙ NACI

Updated guidance on the use of COVID-19 vaccines in individuals who have not previously been vaccinated against COVID-19

2023 ∙ NACI

Guidance on the use of COVID-19 vaccines in the fall of 2023

2023 ∙ NACI

NACI Interim guidance on the use of bivalent Omicroncontaining COVID-19 vaccines for primary series

2023 ∙ NACI

Guidance on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19

2023 ∙ NACI

NACI guidance on COVID-19 vaccine booster doses: Initial considerations for 2023

2022 ∙ Cénat, J. M. Noorishad, P. G. Bakombo, S. M. Onesi, O. Mesbahi, A. Darius, W. P. Caulley, L. Yaya, S. Chomienne, M. H. Etowa, J. Venkatesh, V. Dalexis, R. D. Pongou, R. Labelle, P. R.

A Systematic Review on Vaccine Hesitancy in Black Communities in Canada: Critical Issues and Research Failures

2022 ∙ Cénat, J. M. Noorishad, P. G. Moshirian Farahi, S. M. M. Darius, W. P. Mesbahi, A. Onesi, O. Broussard, C. Furyk, S. E. Yaya, S. Caulley, E. Chomienne, M. H. Etowa, J. Labelle, P. R.

COVID-19 Vaccine Hesitancy and Related Factors in Canada: A Systematic Review and Meta-analysis

2022 ∙ NACI

Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration